Erste Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,400
| Closed | -$3.08M | – | 933 |
|
|
2025
Q1 | $3.08M | Hold |
23,400
| – | – | 0.04% | 261 |
|
|
2024
Q4 | $1.99M | Hold |
23,400
| – | – | 0.02% | 327 |
|
|
2024
Q3 | $1.72M | Hold |
23,400
| – | – | 0.02% | 341 |
|
|
2024
Q2 | $1.66M | Hold |
23,400
| – | – | 0.02% | 324 |
|
|
2024
Q1 | $1.63M | Hold |
23,400
| – | – | 0.02% | 326 |
|
|
2023
Q4 | $1.68M | Hold |
23,400
| – | – | 0.02% | 312 |
|
|
2023
Q3 | $1.26M | Hold |
23,400
| – | – | 0.02% | 322 |
|
|
2023
Q2 | $1.45M | Hold |
23,400
| – | – | 0.03% | 320 |
|
|
2023
Q1 | $1.31M | Hold |
23,400
| – | – | 0.03% | 320 |
|
|
2022
Q4 | $1.25M | Hold |
23,400
| – | – | 0.03% | 327 |
|
|
2022
Q3 | $1.06M | Hold |
23,400
| – | – | 0.02% | 350 |
|
|
2022
Q2 | $1.36M | Hold |
23,400
| – | – | 0.03% | 322 |
|
|
2022
Q1 | $1.41M | Buy |
23,400
+2,400
| +11% | +$145K | 0.03% | 328 |
|
|
2021
Q4 | $1.09M | Hold |
21,000
| – | – | 0.02% | 350 |
|
|
2021
Q3 | $752K | Hold |
21,000
| – | – | 0.01% | 364 |
|
|
2021
Q2 | $835K | Hold |
21,000
| – | – | 0.02% | 362 |
|
|
2021
Q1 | $683K | Hold |
21,000
| – | – | 0.02% | 362 |
|
|
2020
Q4 | $655K | Hold |
21,000
| – | – | 0.02% | 367 |
|
|
2020
Q3 | $536K | Buy |
+21,000
| New | +$536K | 0.02% | 347 |
|